Lipid‐lowering therapy use and achievement of cholesterol targets in an Australian diabetes clinic

E-ISSN： 1445-5994|48|2|201-204

ISSN： 1444-0903

Source： INTERNAL MEDICINE JOURNAL, Vol.48, Iss.2, 2018-02, pp. : 201-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Underutilization of Measurement of Serum Low‐Density Lipoprotein Cholesterol Levels and of Lipid‐Lowering Therapy in Older Patients with Manifest Atherosclerotic Disease

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 46, Iss. 9, 1998-09 ,pp. : 1128-1131

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lipid lowering therapy in type 2 diabetes

By Föger Bernhard

Wiener Medizinische Wochenschrift, Vol. 161, Iss. 11-12, 2011-06 ,pp. : 289-296

Springer Publishing Company

Access to resources Recommend Favorite

Beyond lipid-lowering therapy: does ezetimibe enhance the effects of statins on atherosclerosis?

By Krishnamoorthy Suresh Lip Gregory YH

Therapy, Vol. 5, Iss. 4, 2008-07 ,pp. : 487-489

Future Medicine

Access to resources Recommend Favorite

Pioglitazone boosts conventional lipid-lowering therapy for familial combined hyperlipidemia

Future Lipidology, Vol. 2, Iss. 3, 2007-06 ,pp. : 259-261

Future Medicine

Access to resources Recommend Favorite

Meta-Analysis of Lipid-Lowering Therapy in Maintenance Dialysis Patients

Nephron Clin Pract, Vol. 124, Iss. 3-4, 2014-01 ,pp. : 209-217

Karger

Access to resources Recommend Favorite